Rebecca Spescha

Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Barco, Davide Voci, Ulrike Held et al. · The Lancet Haematology · 2022 · 59 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Incidence of Stent Thrombosis after Endovascular Treatment of Iliofemoral or Caval Veins in Patients with the Postthrombotic Syndrome

Tim Sebastian, David Spirk, Rolf P. Engelberger et al. · Thrombosis and Haemostasis · 2019 · 45 citations

Medicine, Surgery, Hemostasis +13

Rivaroxaban or vitamin-K antagonists following early endovascular thrombus removal and stent placement for acute iliofemoral deep vein thrombosis

Tim Sebastian, Lawrence O. Hakki, David Spirk et al. · Thrombosis Research · 2018 · 43 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Deleterious role of endothelial lectin-like oxidized low-density lipoprotein receptor-1 in ischaemia/reperfusion cerebral injury

Alexander Akhmedov, Nicole R. Bonetti, Martin F. Reiner et al. · Journal of Cerebral Blood Flow & Metabolism · 2018 · 27 citations · Full text

Life Sciences, Neuroscience, Apoptosis +15

Cessation of anticoagulation therapy following endovascular thrombus removal and stent placement for acute iliofemoral deep vein thrombosis

Tim Sebastian, Rolf P. Engelberger, David Spirk et al. · VASA · 2019 · 17 citations

Medicine, Surgery, Hemostasis +14